Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have chest pain or other symptoms suggesting reduced blood flow to the heart, and whose coronary artery imaging (either a catheter-based test or a CT scan) has shown that any narrowing in the arteries is less than 70% (not severely blocked)
- People who have signed a consent form agreeing to take part
Who may not be able to join:
- People who have certain medical reasons that make a specific type of nuclear heart scan (called a stress myocardial perfusion scan) unsafe for them — including a heart attack within the past 48 hours, severe narrowing of the main heart artery, asthma, or a known allergy to a medicine called adenosine
- People who have a type of enlarged heart disease not caused by reduced blood flow, a thickened heart muscle condition, or moderate to severe heart valve disease
- People whose blood pressure is dangerously low (below 90 mmHg at the top reading), who require medicines to maintain blood pressure, or who have certain unresolved abnormal heart rhythms or significant heart electrical conduction problems
- People with severely reduced kidney function (eGFR below 30 ml/min) or who are currently on dialysis
- People with a cancer diagnosis where survival is expected to be less than one year
- People who are pregnant or breastfeeding
- People who are unable to be placed inside the trial's heart-scanning device (MCG), including those with metal implants that would interfere with the scan, or anyone the trial doctors consider unsuitable for other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yuguo Chen, Professor, Qliu Hospital of Shandong University
Phone: 0086-0531-82165398
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of MCG to detect myocardial ischemia using SPECT as a reference standard.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.